NICA.ST
Price:
$0.706
Market Cap:
$62.39M
Nanologica AB (publ), a nanotechnology company, develops nanoporous silica for applications in the life science industry. The company offers nanoporous silica particles for drug development and chromatography separation. It provides NLAB Silica, a technology platform for drug delivery; NLAB Spiro, an inhalation platform for pulmonary drug delivery; SVEA (U)HPLC analytical columns; and preparative chromatography. Nanologica AB (publ) was founded in 2004 and is based in Södertälje, Sweden.
Industry
Biotechnology
IPO Date
2015-10-30
Stock Exchange
STO
Ticker
NICA.ST
According to Nanologica AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -1.53. This represents a change of -29.93% compared to the average of -2.18 of the last 4 quarters.
The mean historical PE Ratio of Nanologica AB (publ) over the last ten years is -5.25. The current -1.53 PE Ratio has changed 2.81% with respect to the historical average. Over the past ten years (40 quarters), NICA.ST's PE Ratio was at its highest in in the March 2018 quarter at -0.83. The PE Ratio was at its lowest in in the December 2020 quarter at -21.64.
Average
-5.25
Median
-4.65
Minimum
-13.07
Maximum
-1.37
Discovering the peaks and valleys of Nanologica AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 230.81%
Maximum Annual PE Ratio = -1.37
Minimum Annual Increase = -71.87%
Minimum Annual PE Ratio = -13.07
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -1.37 | -71.87% |
| 2023 | -4.88 | -10.41% |
| 2022 | -5.45 | -29.69% |
| 2021 | -7.75 | -40.67% |
| 2020 | -13.07 | 58.62% |
| 2019 | -8.24 | 230.81% |
| 2018 | -2.49 | 10.36% |
| 2017 | -2.26 | -12.50% |
| 2016 | -2.58 | -41.69% |
| 2015 | -4.42 | 102.80% |
The current PE Ratio of Nanologica AB (publ) (NICA.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.90
5-year avg
-6.51
10-year avg
-5.25
Nanologica AB (publ)’s PE Ratio is greater than Biosergen AB (-3.04), less than Active Biotech AB (publ) (-1.44), less than Biovica International AB (publ) (-0.41), less than Xbrane Biopharma AB (publ) (2.22), greater than NextCell Pharma AB (-2.12), greater than Pila Pharma AB (publ) (-5.54), greater than Scandinavian ChemoTech AB (publ) (-12.77), greater than Sprint Bioscience AB (publ) (-5.84), less than Vivesto AB (-0.17), greater than Spago Nanomedical AB (publ) (-1.74),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.04 | $97.50M | |
| -1.44 | $55.36M | |
| -0.41 | $72.58M | |
| 2.22 | $132.42M | |
| -2.12 | $75.52M | |
| -5.54 | $96.79M | |
| -12.77 | $110.98M | |
| -5.84 | $149.83M | |
| -0.17 | $69.73M | |
| -1.74 | $35.53M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nanologica AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nanologica AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Nanologica AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Nanologica AB (publ) (NICA.ST)?
What is the highest PE Ratio for Nanologica AB (publ) (NICA.ST)?
What is the 3-year average PE Ratio for Nanologica AB (publ) (NICA.ST)?
What is the 5-year average PE Ratio for Nanologica AB (publ) (NICA.ST)?
How does the current PE Ratio for Nanologica AB (publ) (NICA.ST) compare to its historical average?